DuPont de Nemours (NYSE:DD) 주식

DuPont de Nemours

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025, which will be named Qnity.

benzinga_deal_dispatch2

News

ABBV

BIIB

LNTH

NGVT

NPSCY

RVNC

SAGE

SANW

SLRX

TMUS

대통령 조 바이든은 백악관에서의 마지막 며칠 동안 비폭력 마약 범죄자 석방를 우선시했지만, 틱톡? 이제는 대통령 당선자 도널드 트럼프의 문제이다. AP 통신에 따르면, 바이든은 금지 조치를 시행할 의사가 없으며, 이는 그의 마지막 정식 근무일인 1월 19일에 발효되고 트럼프의 취임식 하루 전이다.

딜 디스패치: 바이든이 틱톡 금지를 트럼프에게 넘기고, 또 다른 유명 소매업체 파산

Chess, China vs US

Asia

Government

Regulations

Eurozone

Politics

Global

Markets

AHKSY

BASFY

MTLHY

SABRY

중국은 미국과 유럽 연합에서 만든 플라스틱에 대한 새로운 반덤핑 조사를 시작하면서 서구와의 현재 진행 중인 경제 전쟁에서 새로운 단계를 밟았다. 이번 조치는 최근 조 바이든 대통령이 주도한 중국산 수입품에 대한 관세 인상 등 서방 국가들의 최근 보호주의 조치에 대한 보복 조치로 읽힐 수 있다.

중국, 바이든의 관세에 대응하여 새로운 플라스틱 수입 조사로 반격: 6개 주식이 피해 우려

DuPont de Nemours Inc

DDC Enterprise Limited Class A Ordinary Shares

DDC Enterprise Ltd

BRANICKS GROUP AG SHS by BRANICKS GROUP AG

Branicks Group AG

DIFFUSE DIGITAL 30 LP UT by DIFFUSE DIGITAL 30 LP UNIT LTD.

3D Systems Corp

DIGITAL DAY AGENCY INC by Digital Day Agency, Inc.

3DX INDUSTRIES INC by 3DX Industries Inc.

3DX Industries Inc

FT Vest U.S. Equity Deep Buffer ETF - December

Dundee Corp

DDH1 Ltd Ordinary Shares

DIGITAL DOMAIN HLDG S/ADR by Digital Domain Holdings Limited

Dream Impact Trust

DREAM IMPACT TRUST UNIT by Dream Impact Trust

DoubleDown Interactive Co., Ltd. - American Depository Shares

DoubleDown Interactive Co Ltd

Margaret Lake Diamonds Inc

DuckDaoDime

First Trust Dorsey Wright Momentum & Dividend ETF

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Dingdong (Cayman) Ltd

WisdomTree Dynamic International SmallCap Equity Fund

ProShares Ultra Dow30

DAIHATSU INFINEARTH MFG by DAIHATSU INFINEARTH MFG CO LTD.

Daihatsu Infinearth Mfg Co Ltd

Adamera Minerals Corp

ADAMERA MINERALS CORP by Adamera Minerals Corp.

Datadog Inc

DAIDOH LTD by DAIDOH LTD

disBalancer

CORERO NETWORK SEC PLC by Corero Network Security plc

Corero Network Security PLC

DIVERSIFIED RES INC by Diversified Resources, Inc.

DOLPHIN DRILLING AS by DOLPHIN DRILLING AS

Dolphin Drilling AS

Dillard's Inc

Dillard's Capital Trust I

DAIKO DENSHI TSUSHIN LTD by DAIKO DENSHI TSUSHIN LTD.

WisdomTree Dynamic International Equity Fund

DIVIDEND GROWTH SPLIT A by Dividend Growth Split Corp.

Dividend Growth Split Corp

DerivaDAO - United States Dollar

In the current session, DuPont de Nemours Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is trading at $67.71, after a 0.40% decrease. Over the past month, the stock decreased by 2.48%, and in the past year, by 15.83%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1750172426_0.png" alt="Past Year Chart" />

<h3>Comparing DuPont de Nemours P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 26.3 in the Chemicals industry, DuPont de Nemours Inc. has a higher P/E ratio of 2266.0. Shareholders might be inclined to think that DuPont de Nemours Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1750172426_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: DuPont de Nemours

DuPont de Nemours's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) short percent of float has fallen 9.6% since its last report. The company recently reported that it has 4.19 million shares sold short, which is 1.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.27 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>DuPont de Nemours Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748368825_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for DuPont de Nemours has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing DuPont de Nemours's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, DuPont de Nemours's peer group average for short interest as a percentage of float is 4.47%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into DuPont de Nemours's Recent Short Interest

UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Buy and raises the price target from $79 to $85.

Price Target

Analyst Ratings

UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $85

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4431956-1&amp;h=1503974003&amp;u=http%3A%2F%2Fwww.epicorebiosystems.com%2F&amp;a=Epicore+Biosystems">Epicore Biosystems</a> (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, and DuPont Personal Protection (DuPont) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>), a global leader in personal protection solutions, have agreed to work together to explore opportunities to potentially enhance worker safety and well-being. Drawing on DuPont's expertise in protective garments and Epicore's wearable hydration management technology, this collaboration can help to drive new data analytics and quantitative insights at the intersection of advanced biometrics and personal protective clothing.

Epicore Biosystems And DuPont Personal Protection Agree To Work Together To Explore Opportunities To Potentially Enhance Worker Safety And Well-Being

JP Morgan analyst Stephen Tusa maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Overweight and raises the price target from $78 to $93.

JP Morgan Maintains Overweight on DuPont de Nemours, Raises Price Target to $93

Qnity&#x2122; Branding Symbolizes the Power of Innovation and Partnership
WILMINGTON, Del., May 14, 2025 /PRNewswire/ -- DuPont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) today unveiled the branding of Qnity, the planned independent Electronics public company that will be created through the intended spin-off of its Electronics business&#x2A;. As a pure-play electronics materials company, Qnity will be one of the largest and broadest solutions providers to the semiconductor and electronics industries enabling advanced computing, smart technologies and connectivity. Qnity (pronounced cue-ni-tee) is inspired by 'Q', the symbol for electrical charge, and 'unity'.

Dupont Unveils Branding Of Qnity, Planned Independent Electronics Public Company To Be Created Through Intended Spin-off Of Electronics Business

WIIM

AVNT

AXTA

CENX

MATV

MEOH

MTUS

PACK

TANH

TROX

Shares of companies within the broader materials sector are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A decrease of trade tensions could reduce demand uncertainty for materials.

KeyBanc Capital Markets analyst Aleksey Yefremov reiterated an Overweight rating on DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) on Sunday and raised the price target from $81.00 to $85.00.
DuPont posted a strong <a href="https://www.benzinga.com/news/earnings/25/05/45170554/dupont-delivers-strong-q1-highlights-electronics-spin-off-confirms-2025-guidance" target="_blank" rel="noreferrer noopener">first-quarter 2025</a> earnings beat, driven by sustained growth in its electronics, water, and healthcare segments. The company reaffirmed its full-year 2025 guidance and confirmed that the planned spin-off of its Electronics business is on track for Nov. 1, 2025.
The analyst noted that DuPont has seen no signs of a broader demand slowdown as of April. Strength in water and healthcare is expected to more than offset continued softness in the automotive and construction markets. As a result, the price target was increased to $85, reflecting enhanced confidence in DuPont&#8217;s growth outlook and more optimistic earnings expectations.
The Electronics segment saw a Q1 boost, partly due to demand pull-forward in China, with full-year growth on track at 6–7% and no slowdown in key drivers like advanced semiconductor nodes and packaging, wrote the analyst.
Related: <a href="https://www.benzinga.com/25/05/45196554/these-analysts-boost-their-forecasts-on-dupont-after-upbeat-results" target="_blank" rel="noreferrer noopener">These Analysts Boost Their Forecasts On DuPont After Upbeat Results</a>
Tariffs had a smaller-than-anticipated impact, estimated at just $0.10 per share for 2025, with potential for further mitigation. After accounting for potential tariff impacts, the analyst forecasts that the underlying EBITDA will be approximately $3.290 billion, with EPS projected at $4.25.
DuPont expects adjusted EPS of $4.30–$4.40, revenue between $12.8 billion and $12.9 billion, and Operating EBITDA of $3.325 billion—$3.375 billion.
The analysts&#8217; estimates for EBITDA and EPS are slightly lower than DuPont&#8217;s guidance due to concerns over weaker construction and auto markets and the potential impact of tariffs.
The analyst also noted that DuPont does not foresee additional risks to Tyvek in China beyond the current investigation. While the investigation is ongoing, sales continue as usual. Tyvek sales in China account for less than 1% of DuPont&#8217;s total sales.
Price Action: DD shares were down 2.8% to $65.37 on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45205780/5-sp-500-stocks-that-defy-sell-in-may-myth-with-strong-historical-gains">S&amp;P 500 Stocks That Defy &#8216;Sell In May&#8217; Myth: 5 Companies With Strong Historical Gains</a></li>
</ul>
Photo: Shutterstock

Analyst Color

DuPont Analyst Sees Strength In Q1 Results, Electronics Growth, 2025 Outlook

DuPont de Nemours Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) posted better-than-expected first-quarter 2025 <a href="https://www.benzinga.com/quote/DD/earnings">results on Friday</a>.
The company reported sales growth of 5% year-over-year to $3.07 billion, beating the consensus of $3.04 billion. Organic sales increased by +6% YoY, with an 8% volume boost offset by 2% lower prices. Electronics, healthcare and water drove volume gains. Adjusted EPS for the quarter was $1.03 (+30% YoY), beating the consensus of $0.79.
"We continue to benefit from ongoing strength in electronics markets as well as strong demand in healthcare and water end-markets. Through April, we continued to see strong order patterns consistent with our expectations," said Lori Koch, DuPont's CEO.
For the second quarter, DuPont expects net sales of ~$3.20 billion versus the consensus of $3.25 billion and Adjusted EPS of ~$1.05 versus the consensus of $1.08.
DuPont said it sees 2025 adjusted EPS of $4.30–$4.40 versus the $4.34 consensus and expects revenue of $12.8 billion-$12.9 billion versus the $12.92 billion consensus.
DuPont shares fell 0.8% to trade at $66.72 on Monday.
These analysts made changes to their price targets on DuPont following earnings announcement.
<ul>
<li>Morgan Stanley analyst Vincent Andrews maintained DuPont de Nemours with an Equal-Weight rating and lowered the price target from $94 to $80.</li>
<li>Keybanc analyst Aleksey Yefremov maintained DuPont with an Overweight rating and raised the price target from $81 to $85.</li>
</ul>
Considering buying DD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="595" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103128/image-2-17-1024x595.png" alt="" class="wp-image-901568" style="width:638px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103128/image-2-17-1024x595.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103128/image-2-17-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103128/image-2-17-768x447.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103128/image-2-17.png 1087w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45193793/top-3-tech-and-telecom-stocks-that-may-jump-this-quarter">Top 3 Tech And Telecom Stocks That May Jump This Quarter</a> </li>
</ul>
Photo via Shutterstock

Earnings

These Analysts Boost Their Forecasts On DuPont After Upbeat Results

Keybanc analyst Aleksey Yefremov maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Overweight and raises the price target from $81 to $85.

Keybanc Maintains Overweight on DuPont de Nemours, Raises Price Target to $85

Morgan Stanley analyst Vincent Andrews maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Equal-Weight and lowers the price target from $94 to $80.

Morgan Stanley Maintains Equal-Weight on DuPont de Nemours, Lowers Price Target to $80

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index was in the &#8220;Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday following the release of jobs data, with the S&amp;P 500 recording gains for the ninth consecutive day to notch its longest winning streak since Nov. 2004.
All three major averages recorded gains for the second week, with the S&amp;P 500 adding 2.9% and the Dow gaining 3% on the week. The Nasdaq, meanwhile, closed higher by 3.4% for the week.
On the economic data front, nonfarm payrolls rose by 177,000, beating expectations of 130,000 and easing concerns over tariff-related hiring slowdowns. The unemployment rate remained unchanged at 4.2%, as expected. New orders for U.S.-manufactured goods, meanwhile, rose by 4.3% to $618.8 billion in March.
DuPont de Nemours Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) shares rose on Friday after the company's first-quarter 2025 results topped Wall Street estimates.
Most sectors on the S&amp;P 500 closed on a positive note, with financial, communication services, and industrials stocks recording the biggest gains on Friday. However, health care and consumer staples stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 564 points to 41,317.43 on Friday. The S&amp;P 500 gained 1.47% to 5,686.67, while the Nasdaq Composite climbed 1.51% to 17,977.73 during Friday's session.
Investors are awaiting earnings results from Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>), Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>), and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 42.6, the index was in the &#8220;Fear&#8221; zone on Friday, versus a prior reading of 41.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:<a href="https://www.benzinga.com/25/05/45164497/jim-cramer-this-financial-stock-is-a-buy-likes-exlservice-holdings"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/05/45164497/jim-cramer-this-financial-stock-is-a-buy-likes-exlservice-holdings">Jim Cramer: Sunrun Had &#8216;Bad Couple Of Quarters,&#8217; ExlService Holdings Is &#8216;Solid&#8217;</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

S&P 500 Notches Longest Win Streak In Over 2 Decades: Investor Sentiment Improves, Greed Index In 'Fear' Zone

DuPont de Nemours Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) shares are trading lower despite the company&#8217;s <a href="https://www.benzinga.com/pressreleases/25/05/n45160759/dupont-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">first-quarter 2025 results</a> beating Wall Street estimates.
The company reported sales growth of 5% year-over-year to $3.07 billion, beating the consensus of $3.04 billion. Organic sales increased by +6% YoY, with an 8% volume boost offset by 2% lower prices. Electronics, healthcare and water drove volume gains.
Organic sales by region, Asia Pacific rose 13%, EMEA 4%, while the U.S. and Canada were flat. ElectronicsCo grew 14%, IndustrialsCo by 2%.       
DuPont&#8217;s operating EBITDA rose 16% YoY to $788 million, and its margin expanded by 240 bps to 25.7%. Adjusted EPS for the quarter was $1.03 (+30% YoY), beating the consensus of $0.79.
Electronics sales totaled $1.12 billion (+14% YoY), and the operating EBITDA margin expanded by 340 bps to 33.4%. IndustrialsCo sales totaled $1.95 billion (+2% YoY), and the operating EBITDA margin expanded by 130 bps to 23.8%.
&#8220;We continue to benefit from ongoing strength in electronics markets as well as strong demand in healthcare and water end-markets. Through April, we continued to see strong order patterns consistent with our expectations,&#8221; said Lori Koch, DuPont&#8217;s CEO.
&#8220;Our global manufacturing footprint and flexible supply chain network serves us well as we manage through the impact of tariffs,&#8221; Koch continued. &#8220;Our teams are actively engaged with customers and suppliers as we work to further mitigate the impact.&#8221;
The company generated $382 million in operating cash, spent $249 million on capital projects, and paid $79 million in separation costs, yielding $212 million in adjusted free cash flow with a 49% conversion rate.
DuPont reported a GAAP loss due to a $768 million non-cash goodwill impairment tied to its Aramids unit (Nomex&#xAE; and Kevlar&#xAE;) following a 2025 segment realignment and revaluation of assets from the Dow-DuPont merger.
Q2 Outlook: DuPont expects net sales of ~$3.20 billion versus the consensus of $3.25 billion and Adjusted EPS of ~$1.05 versus the consensus of $1.08.
&#8220;Our full year 2025 guidance remains unchanged from our prior outlook. Further, full year guidance does not include a net cost impact of announced tariffs currently estimated at $60 million, or about $0.10 per share,&#8221; said Antonella Franzen, DuPont CFO.
2025 Outlook, reaffirmed: DuPont sees adjusted EPS of $4.30–$4.40 versus the $4.34 consensus and expects revenue of $12.8 billion-$12.9 billion versus the $12.92 billion consensus.
The company expects Operating EBITDA of $3.325 billion–$3.375 billion.&nbsp;&nbsp;&nbsp;
The company confirmed it remains on schedule for the planned Nov. 1, 2025, spin-off of its Electronics business, recently named Qnity. It continues to meet key milestones for the separation, including executive and board appointments and last week&#8217;s filing of the initial Form 10 registration statement with the SEC.
DD Price Action: DuPont shares are trading up 0.98% at $67.70 at publication on Friday.
Read Next: • <a href="https://www.benzinga.com/news/earnings/25/04/45080514/sherwin-williams-reports-mixed-q1-results-in-choppy-demand-environment" target="_blank" rel="noreferrer noopener">Sherwin-Williams Reports Mixed Q1 Results In &#8216;Choppy&#8217; Demand Environment</a>
 Photo: Lalaka via Shutterstock

Guidance

DuPont Delivers Strong Q1, Highlights Electronics Spin-Off, Confirms 2025 Guidance

"Our full year 2025 guidance remains unchanged from our prior outlook. Further, full year guidance does not include a net cost impact of announced tariffs currently estimated at $60 million, or about $0.10 per share," Franzen concluded.&nbsp;

DuPont 2025 Guidance Unchanged: Adj EPS $4.30-$4.40 Vs $4.26 Est; Sales $12.8B-$12.9B Vs $12.74B Est; Excludes Estimated $60M Tariff Cost, Or About $0.10 Per Share

DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is looking for Q2 Adj EPS of $1.05 vs $1.08 analyst estimate. sees sales of $3.200 billion vs $3.25 billion analyst estimate.

DuPont de Nemours Sees Q2 Adj EPS $1.05 vs $1.08 Est; Sees Sales $3.200B vs $3.25B Est

DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.95 by 8.42 percent. This is a 30.38 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $3.07 billion which beat the analyst consensus estimate of $3.04 billion by 0.81 percent. This is a 4.61 percent increase over sales of $2.93 billion the same period last year.

Earnings Beats

DuPont de Nemours Q1 Adj. EPS $1.03 Beats $0.95 Estimate, Sales $3.07B Beat $3.04B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $1.98 billion. 
• Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $79.89 million. 
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $1.43 billion. 
• Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) is expected to report quarterly loss at $0.83 per share on revenue of $1.08 billion. 
• Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $427.39 million. 
• United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $925.42 million. 
• Telephone and Data Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.19 billion. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is likely to report quarterly loss at $0.03 per share on revenue of $415.45 million. 
• Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.25 billion. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $108.98 million. 
• Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $260.12 million. 
• Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $526.63 million. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.70 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.25 per share on revenue of $2.16 billion. 
• SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $351.00 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is projected to report quarterly loss at $0.18 per share on revenue of $71.26 million. 
• Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $205.52 million. 
• Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is likely to report quarterly earnings at $0.50 per share on revenue of $4.18 billion. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its first quarter. 
• Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $421.40 million. 
• nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $790.29 million. 
• Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is projected to report quarterly loss at $0.25 per share on revenue of $522.45 million. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $295.59 million. 
• Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $273.46 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $39.25 million. 
• City Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIO#NYSE">CIO</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $42.20 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $168.05 million. 
• AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $3.10 billion. 
• Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $85.63 million. 
• Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $559.99 million. 
• T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) is projected to report quarterly earnings at $2.13 per share on revenue of $1.78 billion. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is estimated to report quarterly earnings at $2.71 per share on revenue of $6.25 billion. 
• Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $4.64 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $2.95 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is likely to report quarterly earnings at $2.18 per share on revenue of $48.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $9.68 billion. 
• ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) is estimated to report earnings for its first quarter. 
• Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is expected to report quarterly earnings at $1.65 per share on revenue of $79.13 billion. 
• IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) is projected to report earnings for its second quarter. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $9.73 billion. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $367.73 million. 
• Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $123.71 million. 
• Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) is estimated to report quarterly earnings at $6.35 per share on revenue of $60.39 billion. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.74 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $715.49 million. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $3.04 billion. 
• inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is likely to report quarterly loss at $0.10 per share on revenue of $28.07 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is projected to report quarterly loss at $0.07 per share on revenue of $21.16 million. 
• Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $297.11 million. 
• Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) is projected to report quarterly loss at $0.09 per share on revenue of $72.98 million. 
• NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) is expected to report earnings for its first quarter. 
• AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $347.25 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $86.09 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

AMRX

ASIX

ATMU

BBUC

BEPC

BFLY

BTSG

CBOE

CRTO

FLGT

FUBO

IESC

INTT

JOUT

LBTYA

MSGS

PIPR

PRLB

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SHEL

TILE

TROW

VNCE

WLKP

Earnings Scheduled For May 2, 2025

DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is gearing up to announce its quarterly earnings on Friday, 2025-05-02. Here's a quick overview of what investors should know before the release.
Analysts are estimating that DuPont de Nemours will report an earnings per share (EPS) of $0.95.
The market awaits DuPont de Nemours's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
The company's EPS beat by $0.15 in the last quarter, leading to a 0.34% increase in the share price on the following day.
Here's a look at DuPont de Nemours's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.98</td>
<td>1.03</td>
<td>0.85</td>
<td>0.65</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.13</td>
<td>1.18</td>
<td>0.97</td>
<td>0.79</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746108111_0.png" alt="eps graph" />
<h3>Market Performance of DuPont de Nemours's Stock</h3>
Shares of DuPont de Nemours were trading at $65.99 as of April 30. Over the last 52-week period, shares are down 14.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Insights Shared by Analysts on DuPont de Nemours</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on DuPont de Nemours.
A total of 14 analyst ratings have been received for DuPont de Nemours, with the consensus rating being Outperform. The average one-year price target stands at $86.36, suggesting a potential 30.87% upside.
<h3>Analyzing Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of PPG Indus, Intl Flavors &amp; Fragrances and RPM Intl, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for PPG Indus, with an average 1-year price target of $124.25, suggesting a potential 88.29% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Intl Flavors &amp; Fragrances, with an average 1-year price target of $93.69, suggesting a potential 41.98% upside.</li>
<li>Analysts currently favor an Neutral trajectory for RPM Intl, with an average 1-year price target of $114.43, suggesting a potential 73.41% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for PPG Indus, Intl Flavors &amp; Fragrances and RPM Intl, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>DuPont de Nemours</td>
<td>Outperform</td>
<td>6.69%</td>
<td>$1.12B</td>
<td>-0.50%</td>
</tr>
<tr>
<td>PPG Indus</td>
<td>Neutral</td>
<td>-7.72%</td>
<td>$755M</td>
<td>-3.84%</td>
</tr>
<tr>
<td>Intl Flavors &amp; Fragrances</td>
<td>Outperform</td>
<td>2.52%</td>
<td>$980M</td>
<td>-0.32%</td>
</tr>
<tr>
<td>RPM Intl</td>
<td>Neutral</td>
<td>-3.05%</td>
<td>$567.49M</td>
<td>1.92%</td>
</tr>
</tbody>
</table>

Key Takeaway:
DuPont de Nemours has the highest revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity.
<h3>All You Need to Know About DuPont de Nemours</h3>
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
<h3>DuPont de Nemours: Delving into Financials</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, DuPont de Nemours showcased positive performance, achieving a revenue growth rate of 6.69% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: DuPont de Nemours's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -3.82%, the company may face hurdles in effective cost management.
Return on Equity (ROE): DuPont de Nemours's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.5%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): DuPont de Nemours's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.32%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.31.
<a href="https://www.benzinga.com/quote/DD/earnings">To track all earnings releases for DuPont de Nemours visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Peek at DuPont de Nemours's Future Earnings

Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $86.36, a high estimate of $112.00, and a low estimate of $73.00. This current average represents a 9.91% decrease from the previous average price target of $95.86. 
<img src="https://www.benzinga.com/files/images/story/2025/1745956885_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of DuPont de Nemours's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Duffy Fischer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$73.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$75.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Bradley Thomas</td>
<td>Keybanc</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$74.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$103.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$112.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$89.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$107.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to DuPont de Nemours. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of DuPont de Nemours compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of DuPont de Nemours's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of DuPont de Nemours's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on DuPont de Nemours analyst ratings.</a>
<h2>Unveiling the Story Behind DuPont de Nemours</h2>
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
<h3>DuPont de Nemours's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: DuPont de Nemours's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 6.69%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: DuPont de Nemours's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -3.82% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): DuPont de Nemours's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.5%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.32%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.31, DuPont de Nemours adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing DuPont de Nemours: Insights From 14 Financial Analysts

Barclays analyst Duffy Fischer maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Equal-Weight and lowers the price target from $89 to $73.

Comments

DuPont de Nemours

뉴스

파트너 / 기고자

벤징가 글로벌